Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anti-RA33 Antibodies Are Present in Patients With Lyme Disease.
Miller JB, Yang T, Rebman AW, Cappelli L, Bingham CO, Villegas de Flores MD, Darrah E, Aucott JN. Miller JB, et al. Among authors: rebman aw. J Clin Rheumatol. 2024 Nov 22. doi: 10.1097/RHU.0000000000002176. Online ahead of print. J Clin Rheumatol. 2024. PMID: 39575669
Precise identification and tracking of HMGCR-reactive CD4+ T cells in the target tissue of patients with anti-HMGCR immune-mediated necrotising myopathy.
Tiniakou E, Girgis A, Siafei T, Albayda J, Adler B, Paik JJ, Mecoli CA, Rebman A, Soloski MJ, Christopher-Stine L, Smith KN, Rosen A, Mammen AL, Darrah E. Tiniakou E, et al. Among authors: rebman a. Ann Rheum Dis. 2024 Oct 11:ard-2024-225732. doi: 10.1136/ard-2024-225732. Online ahead of print. Ann Rheum Dis. 2024. PMID: 39393845
Autoantibodies in post-treatment Lyme disease and association with clinical symptoms.
Keshtkarjahromi M, Rebman AW, Antar AAR, Manabe YC, Gutierrez-Alamillo L, Casciola-Rosen LA, Aucott JN, Miller JB. Keshtkarjahromi M, et al. Among authors: rebman aw. Clin Exp Rheumatol. 2024 Jul;42(7):1487-1490. doi: 10.55563/clinexprheumatol/qcupkk. Epub 2024 Apr 5. Clin Exp Rheumatol. 2024. PMID: 38607687 Free article.
Annexin A2 antibodies in post-treatment Lyme disease.
Miller JB, Rebman AW, de Flores MDV, Wang H, Darrah E, Aucott JN. Miller JB, et al. Among authors: rebman aw. Ther Adv Infect Dis. 2024 Mar 30;11:20499361241242971. doi: 10.1177/20499361241242971. eCollection 2024 Jan-Dec. Ther Adv Infect Dis. 2024. PMID: 38559699 Free PMC article.
Time to Diagnosis and Treatment of Lyme Disease by Patient Race.
Starke SJ, Rebman AW, Miller J, Yang T, Aucott JN. Starke SJ, et al. Among authors: rebman aw. JAMA Netw Open. 2023 Dec 1;6(12):e2347184. doi: 10.1001/jamanetworkopen.2023.47184. JAMA Netw Open. 2023. PMID: 38085545 Free PMC article.
Initial Presentation and Time to Treatment in Early Lyme Disease.
Rebman AW, Yang T, Yoon I, Powell D, Geller SA, Aucott JN. Rebman AW, et al. Am J Trop Med Hyg. 2023 Feb 6;108(4):734-737. doi: 10.4269/ajtmh.22-0437. Print 2023 Apr 5. Am J Trop Med Hyg. 2023. PMID: 36746657 Free PMC article.
50 results